Research Article
Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease
Figure 2
Serum levels of interleukin- (IL-) 22 among the study groups. (a) Serum levels of IL-22 were determined in the control, T2DM, CAD, and T2DM-CAD groups by enzyme-linked immunosorbent assay (ELISA). (b) Serum levels of IL-22 were determined among the CAD subgroups and the control group by ELISA. Values are presented as medians (5th and 95th percentiles). ; versus control group. , T2DM-CAD versus T2DM group; T2DM-CAD versus CAD group.
(a) |
(b) |